Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia
AUTOR(ES)
Rivera-Álvarez, Montserrat; Córdova-Ramírez, Alejandra Carmina; Elías-De-La-Cruz, Gilberto David; Murrieta-Álvarez, Iván; León-Peña, Andrés Aurelio; Cantero-Fortiz, Yahveth; Olivares-Gazca, Juan Carlos; Ruiz-Delgado, Guillermo José; Ruiz-Argüelles, Guillermo José
FONTE
Hematology, Transfusion and Cell Therapy
DATA DE PUBLICAÇÃO
2022
RESUMO
ABSTRACT Introduction: We have previously shown that some patients present thrombocytopenia (less than 100 × 109/L platelets) in non-alcoholic fatty liver disease (NAFLD). To further explore the nature of this association, we have now analyzed the association of thrombocytopenia with neutropenia (less than 0.5 × 109/L granulocytes) in NAFLD. Material and methods: Persons with NAFLD were prospectively accrued in the study after February 2018. The presence of NAFLD was defined by both serologic determinations (Fibromax ®) and liver transient elastography (TE/Fibroscan ®). Results: In 123 consecutive patients with NAFLD without cirrhosis, thrombocytopenia was identified in 20 (16%), whereas neutropenia was identified in 9 (7%). In the subset of 20 patients with NAFLD and thrombocytopenia, granulocytopenia was identified in 5 (25%), whereas in the subset of 9 patients with granulocytopenia, thrombocytopenia was identified in 5 (55%). We found a significant association between thrombocytopenia and both leukopenia and granulocytopenia (OR 8.25, 95% CI 1.9–34.2, p = 0.004). Conclusions: Both thrombocytopenia and neutropenia were identified in persons with NAFLD and, as there is a significant relationship between these two variables, we speculate that this finding may support the possibility of hypersplenism being involved in the cytopenias found in NAFLD without cirrhosis.
Documentos Relacionados
- The association of vitamin D deficiency with non-alcoholic fatty liver disease
- SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE
- Transient elastography in patients with non‐alcoholic fatty liver disease (NAFLD)
- Non‐alcoholic fatty liver disease in patients with HCV genotype 4
- Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease